Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.
Routine care data could supplement traditional trials for advanced lymphoma, expanding treatment options when enrolling patients proves difficult.
This PubMed record reports that our results suggest that EC studies using routine care data could be considered in the development of strategies for advanced Hodgkin lymphoma. It provides randomized controlled trial evidence relevant to Hematologic malignancies.
What the study was
- Study design
- Randomized controlled trial
- Category
- Other
- Maturity
- Validated
- Journal
- Clinical pharmacology and therapeutics
Why it surfaced
Conservative rapid triage based on the PubMed abstract and citation metadata; randomized controlled trial with other relevance.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.